Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Nivolumab 240 / Ipilimumab 1, Carcinoma of Unknown Primary

Protocol-ID: 3091 V1.0 (Mini), NIVO240/IPIL1, CUP

Indication(s)

  • Occult Primary Carcinoma; ICD-10 C80.0
    TMB - Tumor Mutational Burden high
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 31.12.2025